Genetic Deletion of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Homeostasis and Impairs Exercise Tolerance

Overview

Journal bioRxiv

Date 2024 Aug 12

PMID 39131310

Authors

Ji-Hyun Lee

Ik-Rak Jung

Becky Tu-Sekine

Sunghee Jin

Frederick Anokye-Danso

Rexford S Ahima

Sangwon F Kim

Affiliations

Soon will be listed here.

Abstract

Inositol phosphates are critical signaling messengers involved in a wide range of biological pathways in which inositol polyphosphate multikinase (IPMK) functions as a rate-limiting enzyme for inositol polyphosphate metabolism. IPMK has been implicated in cellular metabolism, but its function at the systemic level is still poorly understood. Since skeletal muscle is a major contributor to energy homeostasis, we have developed a mouse model in which skeletal muscle IPMK is specifically deleted and examined how a loss of IPMK affects whole-body metabolism. Here, we report that mice in which IPMK knockout is deleted, specifically in the skeletal muscle, displayed an increased body weight, disrupted glucose tolerance, and reduced exercise tolerance under the normal diet. Moreover, these changes were associated with an increased accumulation of triglyceride in skeletal muscle. Furthermore, we have confirmed that a loss of IPMK led to reduced beta-oxidation, increased triglyceride accumulation, and impaired insulin response in IPMK-deficient muscle cells. Thus, our results suggest that IPMK mediates the whole-body metabolism via regulating muscle metabolism and may be potentially targeted for the treatment of metabolic syndromes.

References

Tu-Sekine B, Padhi A, Jin S, Kalyan S, Singh K, Apperson M . Inositol polyphosphate multikinase is a metformin target that regulates cell migration. FASEB J. 2019; 33(12):14137-14146. PMC: 6894044. DOI: 10.1096/fj.201900717RR. View

Hatch A, York J . SnapShot: Inositol phosphates. Cell. 2010; 143(6):1030-1030.e1. PMC: 4299573. DOI: 10.1016/j.cell.2010.11.045. View

Garcia D, Shaw R . AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Mol Cell. 2017; 66(6):789-800. PMC: 5553560. DOI: 10.1016/j.molcel.2017.05.032. View

Illies C, Gromada J, Fiume R, Leibiger B, Yu J, Juhl K . Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science. 2007; 318(5854):1299-302. DOI: 10.1126/science.1146824. View

Krssak M, Falk Petersen K, Dresner A, Dipietro L, Vogel S, Rothman D . Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999; 42(1):113-6. DOI: 10.1007/s001250051123. View

Kleinert M, Parker B, Chaudhuri R, Fazakerley D, Serup A, Thomas K . mTORC2 and AMPK differentially regulate muscle triglyceride content via Perilipin 3. Mol Metab. 2016; 5(8):646-655. PMC: 5021677. DOI: 10.1016/j.molmet.2016.06.007. View

Rao F, Xu J, Fu C, Cha J, Gadalla M, Xu R . Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1. Proc Natl Acad Sci U S A. 2015; 112(6):1773-8. PMC: 4330756. DOI: 10.1073/pnas.1424642112. View

Dubois E, Dewaste V, Erneux C, Messenguy F . Inositol polyphosphate kinase activity of Arg82/ArgRIII is not required for the regulation of the arginine metabolism in yeast. FEBS Lett. 2000; 486(3):300-4. DOI: 10.1016/s0014-5793(00)02318-8. View

Jaiswal N, Gavin M, Quinn 3rd W, Luongo T, Gelfer R, Baur J . The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis. Mol Metab. 2019; 28:1-13. PMC: 6822261. DOI: 10.1016/j.molmet.2019.08.001. View

10.

He J, Watkins S, Kelley D . Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes. 2001; 50(4):817-23. DOI: 10.2337/diabetes.50.4.817. View

11.

Muoio D . Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell. 2014; 159(6):1253-62. PMC: 4765362. DOI: 10.1016/j.cell.2014.11.034. View

12.

Fujimoto B, Young M, Nakamura N, Ha H, Carter L, Pitts M . Disrupted glucose homeostasis and skeletal-muscle-specific glucose uptake in an exocyst knockout mouse model. J Biol Chem. 2021; 296:100482. PMC: 8027262. DOI: 10.1016/j.jbc.2021.100482. View

13.

Kelley D, He J, Menshikova E, Ritov V . Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002; 51(10):2944-50. DOI: 10.2337/diabetes.51.10.2944. View

14.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

15.

Sylow L, Kleinert M, Richter E, Jensen T . Exercise-stimulated glucose uptake - regulation and implications for glycaemic control. Nat Rev Endocrinol. 2016; 13(3):133-148. DOI: 10.1038/nrendo.2016.162. View

16.

Fujii N, Ho R, Manabe Y, Jessen N, Toyoda T, Holland W . Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes. 2008; 57(11):2958-66. PMC: 2570392. DOI: 10.2337/db07-1187. View

17.

ONeill B, Lauritzen H, Hirshman M, Smyth G, Goodyear L, Kahn C . Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. Cell Rep. 2015; 11(8):1220-35. PMC: 4449334. DOI: 10.1016/j.celrep.2015.04.037. View

18.

Warram J, Martin B, Krolewski A, Soeldner J, Kahn C . Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990; 113(12):909-15. DOI: 10.7326/0003-4819-113-12-909. View

19.

Benjamin D, Louie S, Mulvihill M, Kohnz R, Li D, Chan L . Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness. ACS Chem Biol. 2014; 9(6):1340-50. PMC: 4076040. DOI: 10.1021/cb5001907. View

20.

Irvine R, Schell M . Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol. 2001; 2(5):327-38. DOI: 10.1038/35073015. View